NanoVibronix Inc (OQ:NAOV)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
See Regulatory Filings on SEC
Company Contact
Address: 525 Executive Blvd
ELMSFORD NY 10523-1240
Tel: N/A
IR: See website
Key People
Christopher M. Fashek
Chairman of the Board
William Stern
Brian M. Murphy
Chief Executive Officer, Director
Stephen Russell Brown
Chief Financial Officer
Harold Jacob
Chief Medical Officer, Director
Business Overview
NanoVibronix, Inc. is a medical device company focusing on noninvasive biological response-activating devices that target wound healing and pain therapy. The Company's products include PainShield, WoundShield and UroShield. Its products under development include Renooskin and Endotrachshield. The Company's principal research and development activities are conducted in Israel, through its subsidiary, NanoVibronix (Israel 2003) Ltd. The Company operates in the United States, Europe and India, among others. The PainShield is a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. The Company's WoundShield system is a patch-based therapeutic ultrasound device that facilitates tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation.
Financial Overview
For the nine months ended 30 September 2020,NanoVibronix Inc revenues increased 20% to $533K. Net lossdecreased 28% to $3.3M. Revenues reflect United Statessegment increase of 51% to $391K. Lower net loss reflectsStock-based Compensation in General & Ad decrease of 81% to$289K (expense), Warrant modification expense decrease from$412K (expense) to $0K. Basic Earnings per Share excludingExtraordinary Items increased from -$1.11 to -$0.65.
Employees: 10 as of Dec 31, 2019
Reporting Currency: U.S. Dollars
Enterprise value: $11.60M as of Sep 30, 2020
Annual revenue (TTM): $0.62M as of Sep 30, 2020
EBITDA (TTM): -$4.42M as of Sep 30, 2020
Net annual income (TTM): -$4.51M as of Sep 30, 2020
Free cash flow (TTM): -$3.10M as of Sep 30, 2020
Net Debt Last Fiscal Year: N/A
Shares outstanding: 13,393,653 as of Nov 15, 2020
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.